/Investor DB

Fast Track Initiative — 2026 Investments

3 investments dated 2026 · listed companies and verified rows first · show all

Qolyqoly.techFeb 2026✓ verified

Qoly Corporation develops, manufactures, and sells microsurgery-assist robots and related products, using robotics to help surgeons perform precise and safe microsurgery for functional disorders.

HealthtechMedical DevicesRoboticsTokyo, JP

Yohei Kuroda(Representative Director & President (Co-founder))inKazuhito Wakana(Director & CTO (Co-founder))Atsushi Miyamoto(Chief People Officer (Co-founder))Naoki Kobayashi(CFO)

Co-investorsMedVenture Partners, Inc.Development Bank of Japan

Storm Therapeuticsstormtherapeutics.comin𝕏Apr 2026 · $56M

STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.

BiotechHealthtechMedical DevicesWaterbeach, Cambridgeshire, GB

Jerry McMahon, PhD(Chief Executive Officer & President)Professor Tony Kouzarides, PhD, FMedSci, FRS(Director & Founder)

Co-investorsCambridge Innovation CapitalM VenturesPfizer Venture InvestmentsSeroba Life SciencesTaiho Ventures, LLCUTokyo Innovation Platform Co. Ltd.+3 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

SONIRE Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.